see capital allocation as also becoming an important 2H debate for the stock given the growing cash. PAORGAN STANLEY RESEARCH NORTH AMERICA _LC Matthew Harrison r12 714 62:» David Friedman, Key Ratios and Statistics Reuters: BUB.0 Bloomberg: BIIB US Biotechnology / United Stales of America Shr price. cl

normal" rlass=""> = = Download report = =/div> r/td> = = <http://www.morganstanley.com/img/cs/spacer.gif> Editas =edicine: Unequivocal Patent Win Matthew Harrison — Morgan =tanley February 16, 2017 5:02 AM =MT PTAB =eclared no interference-in-fact for Editas licensed CRISPR patents, =nding the interference an